NIAID | Technology Transfer

Major Neutralization Site of Hepatitis E Virus and Use of this Neutralization Site in Methods of Vaccination and in Methods of Screeening for Neutralizing Antibodies to Hepatitis E Virus

Read more about Major Neutralization Site of Hepatitis E Virus and Use of this Neutralization Site in Methods of Vaccination and in Methods of Screeening for Neutralizing Antibodies to Hepatitis E Virus

European Patent
00982311.3
Filed on 2000-11-30

Mutated Anthrax Toxin Protective Antigen Proteins That Specifically Target Cells Containing High Amounts of Cell-Surface Metalloproteinases or Plasminogen Activator Receptors

Read more about Mutated Anthrax Toxin Protective Antigen Proteins That Specifically Target Cells Containing High Amounts of Cell-Surface Metalloproteinases or Plasminogen Activator Receptors

European Patent
00989184.7
Filed on 2000-09-22

Mutated Anthrax Toxin Protective Antigen Proteins That Specifically Target Cells Containing High Amounts of Cell-Surface Metalloproteinases or Plasminogen Activator Receptors

Read more about Mutated Anthrax Toxin Protective Antigen Proteins That Specifically Target Cells Containing High Amounts of Cell-Surface Metalloproteinases or Plasminogen Activator Receptors

Canada
2385122
Filed on 2000-09-22

Mutated Anthrax Toxin Protective Antigen Proteins That Specifically Target Cells Containing High Amounts of Cell-Surface Metalloprteinases or Plasminogen Activator Receptors

Read more about Mutated Anthrax Toxin Protective Antigen Proteins That Specifically Target Cells Containing High Amounts of Cell-Surface Metalloprteinases or Plasminogen Activator Receptors

Australia
25725/01
Filed on 2000-09-22

Identification of the Domain of Plasmodium Falciparum Erythrocyte Membrane Protein 1(PFEMP1) that Mediates Adhesion to Chondroitin Sulfate A

Read more about Identification of the Domain of Plasmodium Falciparum Erythrocyte Membrane Protein 1(PFEMP1) that Mediates Adhesion to Chondroitin Sulfate A

European Patent
00961513.9
Filed on 2000-09-01

Production Of Recombinant Respiratory Syncytial Viruses Expressing Immune Modulatory Molecules

Read more about Production Of Recombinant Respiratory Syncytial Viruses Expressing Immune Modulatory Molecules

Mexico
2002-000490
Filed on 2000-07-12

Production Of Recombinant Respiratory Syncytial Viruses Expressing Immune Modulatory Molecules

Read more about Production Of Recombinant Respiratory Syncytial Viruses Expressing Immune Modulatory Molecules

Japan
2001-509475
Filed on 2000-07-12

Production Of Recombinant Respiratory Syncytial Viruses Expressing Immune Modulatory Molecules

Read more about Production Of Recombinant Respiratory Syncytial Viruses Expressing Immune Modulatory Molecules

European Patent
00948641.6
Filed on 2000-07-12

Production of Recombinant Respiratory Syncytial Viruses Expressing Immune Modulatory Molecules

Read more about Production of Recombinant Respiratory Syncytial Viruses Expressing Immune Modulatory Molecules

China
00810303.8
Filed on 2000-07-12

Production of Recombinant Respiratory Syncytial Viruses Expressing Immune Modulatory Molecules

Read more about Production of Recombinant Respiratory Syncytial Viruses Expressing Immune Modulatory Molecules

Brazil
PI0013202-0
Filed on 2000-07-12

Subscribe to NIAID